AR and prostate cancer: Because both AR transcriptional activity and the cytoplasmic and/or nuclear levels of β-catenin (Chesire et al, 2002; de la Taille et al, 2003) are elevated in prostate cancer, crosstalk between AR and Wnt/β-catenin signalling pathways may contribute to prostate cancer progression.